Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet beat Q1 expectations with $569 million in revenue and raised its 2025 outlook as global Omnipod adoption drives double-digit growth. Latest Ratings for PODD Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Raymond James Maintains Outperform Feb 2022 Piper Sandler Maintains Neutral View More Analyst Ratings for PODD View…

Read More